The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Amendment) Regulations 2021

Amendment of regulation 2 of the PLPS Regulations

This section has no associated Explanatory Memorandum

2.  In regulation 2(1) of the PLPS Regulations(1) (interpretation), at the appropriate place insert—

“prescription item” means an item available on prescription, whether or not it is supplied in pursuance of a prescription or another basis for supply (for example a serious shortage protocol or a patient group direction);; and

“PTPGD” means a pandemic treatment patient group direction, which is a patient group direction—

(a)

relating to the supply of a prescription only medicine to be used for the prevention of or as a treatment for a disease that is, or in anticipation of it being imminently, pandemic; and

(b)

which is in accordance with regulation 233 of the Human Medicines Regulations 2012(2) (exemption for supply etc under a PGD by a person conducting a retail pharmacy business);.

(1)

Regulation 2 has been amended by S.I. 2015/137, 570, 1862 and 1879, 2016/696 and 1077, 2018/1114, 2019/593, 990 and 1094, and 2020/351 and 1126.

(2)

S.I. 2012/1916; regulation 233 has been amended by S.I. 2013/235, 2015/1053 and 2020/1594.